Lamivudine - 68084-578-21 - (Lamivudine)

Alphabetical Index


Drug Information of Lamivudine

Product NDC: 68084-578
Proprietary Name: Lamivudine
Non Proprietary Name: Lamivudine
Active Ingredient(s): 150    mg/1 & nbsp;   Lamivudine
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Lamivudine

Product NDC: 68084-578
Labeler Name: American Health Packaging
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA202032
Marketing Category: ANDA
Start Marketing Date: 20120201

Package Information of Lamivudine

Package NDC: 68084-578-21
Package Description: 3 BLISTER PACK in 1 CARTON (68084-578-21) > 10 TABLET, FILM COATED in 1 BLISTER PACK (68084-578-11)

NDC Information of Lamivudine

NDC Code 68084-578-21
Proprietary Name Lamivudine
Package Description 3 BLISTER PACK in 1 CARTON (68084-578-21) > 10 TABLET, FILM COATED in 1 BLISTER PACK (68084-578-11)
Product NDC 68084-578
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lamivudine
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20120201
Marketing Category Name ANDA
Labeler Name American Health Packaging
Substance Name LAMIVUDINE
Strength Number 150
Strength Unit mg/1
Pharmaceutical Classes Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of Lamivudine


General Information